You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table PDU-6. Estimated trends in the prevalence of problem and injecting drug use, 2006–11 (rate per 1 000 population aged 15–64): Combined estimates per country
Part (ii) Estimated trends of problem opioid use
| Country | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | Drug use [1] | Method [1] |
|---|---|---|---|---|---|---|---|---|
| Czech Republic | 1.44 | 1.36 | 1.52 | 1.63 | 1.48 | 1.27 | POU | TM |
| Germany * | 2.70 | 2.61 | 3.11 | 2.93 | 3.17 | POU | TM | |
| Greece | 2.70 | 2.73 | 2.68 | 3.19 | 2.99 | 2.72 | POU | CR |
| Spain | 1.35 | 1.32 | 1.26 | 1.15 | 1.20 | POU | TM | |
| Italy | 5.78 | 5.60 | 5.50 | 5.46 | 5.51 | 4.80 | POU | TM |
| Cyprus | 1.13 | 2.94 | 1.50 | 1.86 | 1.14 | 1.57 | POU | TP |
| Malta | 5.40 | : | : | : | 6.07 | 7.47 | POU | CR |
| Austria | 4.50 | 4.14 | 4.38 | 5,9** | 5.90 | 5.30 | POU | CR |
| Slovakia | 2.70 | 2.50 | 1.25 | : | : | POU | OT | |
| Turkey*** | 0.54 | 0.36 | 0.26 | POU | MM |
Notes:
Data represents a selection based on the availability of the same calculation method over the time. In some countries more estimates might be available. The selection was made in order for the trend to be unbiased. In some countries data are insufficient to report.
Target groups may vary between countries owing to different methods and data sources; therefore comparisons should be made with caution.
The original age range for Malta in 2006 is 12 to 64 years old.
[1] - POU = Problem opioid use; PSU = Problem stimulant use; IDU = Injecting drug use; PDU = Problem drug use. TM = Treatment Multiplier ; HM = HIV Multiplier ; MM = Mortality Multiplier ; MI = Multivariate Indicator Method ; PM = Police Multiplier ; TP = Truncated Poisson ; CM = Combined Methods. CR = Capture Recapture, OT = Other Methods.
* The figure shown is based on average between the lower and upper bound of prevalence estimate from TM method (that is, no data from PM or MM are included in the figures of this table)
**2009 estimates have been updated since last year's report
*** Original estimates for 15 to 69 age group were recalculated to meet the 15 to 64 age group
Sources:
2013 REITOX National Reports - Fonte PDU template